Effect of Breather in COPD Patients With Intermittent Claudication (NCT06529185) | Clinical Trial Compass
RecruitingNot Applicable
Effect of Breather in COPD Patients With Intermittent Claudication
Egypt60 participantsStarted 2024-07-30
Plain-language summary
The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.
Who can participate
Age range50 Years – 60 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
* All patients will be clinically and medically stable when attending the study.
* Body mass index (BMI) is 18.5 to 24.9 kg/m2.
* History of unilateral exertional leg pain,
* Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
* And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.
Exclusion Criteria:
* cardiovascular insufficiency,
* Recent myocardial infarction,
* heart failure,
* arrhythmia,
* DVT,
* Intracranial hypertension,
* Pneumonia,
* kidney failure,
* fractures,
* uncooperative patients,
* cognitive impairment preventing a patient from participation in exercises.